ASGCT 2026 Annual Meeting, Boston, May 11-15

The ASGCT Annual Meeting stands as the definitive global stage for the gene and cell therapy community—uniting the scientists and industry leaders driving this transformative field. PackGene is thrilled to join this year’s summit to showcase how our high-performance AAV, lentiviral, mRNA, and plasmid platforms are fueling innovation from bench to bedside. From foundational research to clinical-grade manufacturing, our end-to-end solutions are purpose-built to turn the promise of genetic medicine into life-changing reality. Visit us at booth 1531 to see how we can accelerate your path to the clinic.

• Date: May 11-15, 2026
• Venue: Thomas M. Menino Convention Center
• Booth: 1531
• Contact: Jin Qiu, Director Market Development, info@packgene.com

• 1217. Qualifying mass photometry performance for AAV empty/full ratio measurement using native reference standards. (05/12/2026)
• 2414. Decoupling efficacy from toxicity: engineering spatial control in AAV-mediated gene therapy to mitigate hepatotoxicity. (05/14/2026)
• 3215. A fast extraction-free RT-qPCR assay utilizing dual DNA/RNA targeting for rapid mycoplasma detection in CGT products. (05/14/2026)
• 3216. Establishment of serotype-specific rcAAV reference samples to enhance testing sensitivity and specificity for AAV manufacturing. (05/14/2026)

130. Advancing AAV manufacturing through scalable cell line development, high-cell-density transfection, and robust purification process development
Date and Time: 05/13/2026,  9:00 AM - 9:15 AM
Session Room: MCEC Room 258ABC (Level 2)

267. Implementation of upstream mitigation strategies to minimize residual plasmid backbone and host cell DNA encapsidation in rAAV vectors
Session Date and Time: 05/14/2026,  9:00 AM - 9:15 AM
Session Room: MCEC Room 204AB (Level 2)